Oncological Disease
 European School of Haematology    Multinational Association of Supportive Care in Cancer    The European Organisation for the Research and Treatment of Cancer    European Society of Gynaecological Oncology 
Oncological Disease » Articles » Pediatric Urologic Oncology
Thursday, 04 December, 2008



Pediatric Urologic Oncology

Hsi-Yang Wu, MD, and Fernando A Ferrer, MD Director, Pediatric Urology Research, Children’s Hospital of Pittsburgh, and Director, Pediatric Urology, Connecticut Children’s Medical Center ,

  Previous     1    2   3    Next  

Pre-pubertal Testis Tumor

These tumors peak in the two- to four-year-old range and are much more benign than adult testis tumors.

They present as a painless mass, although a history of trauma is often volunteered by the patient. Similar to paratesticular RMS, a serum ``HCG and AFP are obtained pre-operatively. A scrotal ultrasound is obtained pre-operatively, the tumor is resected by inguinal orchiectomy,and post-operatively a CT scan of the chest, abdomen, and pelvis is obtained.Yolk sac and teratoma are the most common pathologies reported.

Stage I yolk sac tumors (negative CT scan with appropriate drop in AFP) do not require chemotherapy. However, patients are required to maintain a vigorous program of surveillance with AFPs, chest X-rays, and CTs for two years. Patients with stage II disease receive cis-platinum, etopiside, bleomycin (PEB), no RT, and can expect a 99% survival. Patients with stage II disease with persistent mass or persistent elevated AFP after chemotherapy should have RPLND. Those in stage III (retroperitoneal lymph nodes) and stage IV (distant metastases) undergo chemotherapy and RPLND.

Overall survival for all stages approaches 100%.29 Teratomas can be managed with testis-sparing surgery in the pre-pubertal patient, because they do not show metastatic behavior as they do in adults.The scrotal ultrasound will show a relatively heterogeneous mass compared with yolk sac tumor, and the AFP should be normal. If the patient is entering puberty, then a radical orchiectomy should be performed.

  Previous     1    2   3    Next  

Keywords and Categories


Author(s) Biography
Hsi-Yang Wu, MD, is Director of Pediatric Urology Research at the Children’s Hospital of Pittsburgh and Assistant Professor of Urology at the University of Pittsburgh. His clinical interests include pediatric urologic oncology, cryptorchidism, and voiding dysfunction. His National Institutes of Health (NIH)- supported laboratory studies neural and smooth muscle maturation in pediatric bladder function, with an aim to develop new treatments for pediatric urinary incontinence.
Fernando A Ferrer, MD, is Director of Pediatric Urology at Connecticut Children’s Medical Center and Assistant Professor of Surgery (Urology), Pediatrics, and Oncology at the University of Connecticut. His clinical interests include pediatric urologic oncology and major reconstructive surgery for urinary continence. He serves on the Children’s Oncology Group (COG) committees that study Wilms’ tumor (Renal Tumor Committee) and late complications (Late Effects Committee), and is involved in developing new protocols for tumor treatment.

Send Article Feedback
Title*:

Comment*:

Name*:
Email Address*:
Location*:

Add me to mailing list

I Agree to terms and conditions


Order Reprint


Order high-quality repints of any
articles on this website


Instructions for Authors
Instructions for authors, click here for details

Submit an Article
Submit an article, click here for details

  Copyright Touch Briefings 2005 - 2008    Terms & Conditions | Privacy Statement|

Articles : a b c d e f g h i j k l m n o p q r s t u v w x y z
Companies : a b c d e f g h i j k l m n o p q r s t u v w x y z
Events : a b c d e f g h i j k l m n o p q r s t u v w x y z
Keywords : a b c d e f g h i j k l m n o p q r s t u v w x y z

Specialities :

Brain Tumor